Mm has been used in trials studying the treatment of Cocaine Dependence and Diabetes Mellitus, Type 2.
Fitur visualisasi ini dikembangkan menggunakan pendekatan Graph Theory untuk memetakan hubungan polifarmasi dan molekuler. Entitas (Obat, Target, Gen) direpresentasikan sebagai Simpul (Nodes), sedangkan hubungan biologisnya sebagai Sisi (Edges).
drugbank-id dan name pada skema XML DrugBank.targets/target yang memuat polipeptida sasaran.gene-name dan varian snp-effects.Tata letak grafik menggunakan algoritma Force-Directed Graph (Barnes-Hut). Model fisika ini menerapkan gaya tolak-menolak antar simpul (Gravitasi: -3000) agar tidak tumpang tindih, serta gaya pegas (Spring: 0.04) pada garis penghubung untuk fleksibilitas interaksi.
| Cyclosporine | The risk or severity of hyperkalemia can be increased when Cyclosporine is combined with Mannitol busulfan. |
| Icosapent | The risk or severity of hyperkalemia can be increased when Icosapent is combined with Mannitol busulfan. |
| Valsartan | The risk or severity of hyperkalemia can be increased when Valsartan is combined with Mannitol busulfan. |
| Ramipril | The risk or severity of hyperkalemia can be increased when Ramipril is combined with Mannitol busulfan. |
| Esmolol | The risk or severity of hyperkalemia can be increased when Esmolol is combined with Mannitol busulfan. |
| Betaxolol | The risk or severity of hyperkalemia can be increased when Betaxolol is combined with Mannitol busulfan. |
| Fluconazole | The risk or severity of hyperkalemia can be increased when Fluconazole is combined with Mannitol busulfan. |
| Succinylcholine | The risk or severity of hyperkalemia can be increased when Succinylcholine is combined with Mannitol busulfan. |
| Mesalazine | The risk or severity of hyperkalemia can be increased when Mesalazine is combined with Mannitol busulfan. |
| Metoprolol | The risk or severity of hyperkalemia can be increased when Metoprolol is combined with Mannitol busulfan. |
| Isradipine | The risk or severity of hyperkalemia can be increased when Isradipine is combined with Mannitol busulfan. |
| Olmesartan | The risk or severity of hyperkalemia can be increased when Olmesartan is combined with Mannitol busulfan. |
| Indomethacin | The risk or severity of hyperkalemia can be increased when Indomethacin is combined with Mannitol busulfan. |
| Atenolol | The risk or severity of hyperkalemia can be increased when Atenolol is combined with Mannitol busulfan. |
| Diltiazem | The risk or severity of hyperkalemia can be increased when Diltiazem is combined with Mannitol busulfan. |
| Trimethadione | The risk or severity of hyperkalemia can be increased when Trimethadione is combined with Mannitol busulfan. |
| Timolol | The risk or severity of hyperkalemia can be increased when Timolol is combined with Mannitol busulfan. |
| Amlodipine | The risk or severity of hyperkalemia can be increased when Amlodipine is combined with Mannitol busulfan. |
| Triamterene | The risk or severity of hyperkalemia can be increased when Triamterene is combined with Mannitol busulfan. |
| Digoxin | The risk or severity of hyperkalemia can be increased when Digoxin is combined with Mannitol busulfan. |
| Nimodipine | The risk or severity of hyperkalemia can be increased when Nimodipine is combined with Mannitol busulfan. |
| Nisoldipine | The risk or severity of hyperkalemia can be increased when Nisoldipine is combined with Mannitol busulfan. |
| Ardeparin | The risk or severity of hyperkalemia can be increased when Ardeparin is combined with Mannitol busulfan. |
| Spironolactone | The risk or severity of hyperkalemia can be increased when Mannitol busulfan is combined with Spironolactone. |
| Trimethoprim | The risk or severity of hyperkalemia can be increased when Trimethoprim is combined with Mannitol busulfan. |
| Nabumetone | The risk or severity of hyperkalemia can be increased when Nabumetone is combined with Mannitol busulfan. |
| Ketorolac | The risk or severity of hyperkalemia can be increased when Ketorolac is combined with Mannitol busulfan. |
| Tenoxicam | The risk or severity of hyperkalemia can be increased when Tenoxicam is combined with Mannitol busulfan. |
| Celecoxib | The risk or severity of hyperkalemia can be increased when Celecoxib is combined with Mannitol busulfan. |
| Sotalol | The risk or severity of hyperkalemia can be increased when Sotalol is combined with Mannitol busulfan. |
| Fosinopril | The risk or severity of hyperkalemia can be increased when Fosinopril is combined with Mannitol busulfan. |
| Tolmetin | The risk or severity of hyperkalemia can be increased when Tolmetin is combined with Mannitol busulfan. |
| Trandolapril | The risk or severity of hyperkalemia can be increased when Trandolapril is combined with Mannitol busulfan. |
| Lercanidipine | The risk or severity of hyperkalemia can be increased when Lercanidipine is combined with Mannitol busulfan. |
| Rofecoxib | The risk or severity of hyperkalemia can be increased when Rofecoxib is combined with Mannitol busulfan. |
| Benazepril | The risk or severity of hyperkalemia can be increased when Benazepril is combined with Mannitol busulfan. |
| Piroxicam | The risk or severity of hyperkalemia can be increased when Piroxicam is combined with Mannitol busulfan. |
| Lamotrigine | The risk or severity of hyperkalemia can be increased when Lamotrigine is combined with Mannitol busulfan. |
| Cinnarizine | The risk or severity of hyperkalemia can be increased when Cinnarizine is combined with Mannitol busulfan. |
| Propranolol | The risk or severity of hyperkalemia can be increased when Propranolol is combined with Mannitol busulfan. |
| Fenoprofen | The risk or severity of hyperkalemia can be increased when Fenoprofen is combined with Mannitol busulfan. |
| Valdecoxib | The risk or severity of hyperkalemia can be increased when Valdecoxib is combined with Mannitol busulfan. |
| Enalapril | The risk or severity of hyperkalemia can be increased when Enalapril is combined with Mannitol busulfan. |
| Diclofenac | The risk or severity of hyperkalemia can be increased when Diclofenac is combined with Mannitol busulfan. |
| Ethosuximide | The risk or severity of hyperkalemia can be increased when Ethosuximide is combined with Mannitol busulfan. |
| Amiloride | The risk or severity of hyperkalemia can be increased when Amiloride is combined with Mannitol busulfan. |
| Labetalol | The risk or severity of hyperkalemia can be increased when Labetalol is combined with Mannitol busulfan. |
| Sulindac | The risk or severity of hyperkalemia can be increased when Sulindac is combined with Mannitol busulfan. |
| Bisoprolol | The risk or severity of hyperkalemia can be increased when Bisoprolol is combined with Mannitol busulfan. |
| Nicardipine | The risk or severity of hyperkalemia can be increased when Nicardipine is combined with Mannitol busulfan. |
| Magnesium sulfate | The risk or severity of hyperkalemia can be increased when Magnesium sulfate is combined with Mannitol busulfan. |
| Losartan | The risk or severity of hyperkalemia can be increased when Losartan is combined with Mannitol busulfan. |
| Moexipril | The risk or severity of hyperkalemia can be increased when Moexipril is combined with Mannitol busulfan. |
| Nitrofurantoin | The risk or severity of hyperkalemia can be increased when Nitrofurantoin is combined with Mannitol busulfan. |
| Eplerenone | The risk or severity of hyperkalemia can be increased when Eplerenone is combined with Mannitol busulfan. |
| Flurbiprofen | The risk or severity of hyperkalemia can be increased when Flurbiprofen is combined with Mannitol busulfan. |
| Lisinopril | The risk or severity of hyperkalemia can be increased when Lisinopril is combined with Mannitol busulfan. |
| Pentamidine | The risk or severity of hyperkalemia can be increased when Pentamidine is combined with Mannitol busulfan. |
| Mannitol | The risk or severity of hyperkalemia can be increased when Mannitol is combined with Mannitol busulfan. |
| Etodolac | The risk or severity of hyperkalemia can be increased when Etodolac is combined with Mannitol busulfan. |
| Mefenamic acid | The risk or severity of hyperkalemia can be increased when Mefenamic acid is combined with Mannitol busulfan. |
| Naproxen | The risk or severity of hyperkalemia can be increased when Naproxen is combined with Mannitol busulfan. |
| Perindopril | The risk or severity of hyperkalemia can be increased when Perindopril is combined with Mannitol busulfan. |
| Sulfasalazine | The risk or severity of hyperkalemia can be increased when Sulfasalazine is combined with Mannitol busulfan. |
| Candesartan cilexetil | The risk or severity of hyperkalemia can be increased when Candesartan cilexetil is combined with Mannitol busulfan. |
| Phenylbutazone | The risk or severity of hyperkalemia can be increased when Phenylbutazone is combined with Mannitol busulfan. |
| Meloxicam | The risk or severity of hyperkalemia can be increased when Meloxicam is combined with Mannitol busulfan. |
| Carprofen | The risk or severity of hyperkalemia can be increased when Carprofen is combined with Mannitol busulfan. |
| Levomenthol | The risk or severity of hyperkalemia can be increased when Levomenthol is combined with Mannitol busulfan. |
| Loperamide | The risk or severity of hyperkalemia can be increased when Loperamide is combined with Mannitol busulfan. |
| Diflunisal | The risk or severity of hyperkalemia can be increased when Diflunisal is combined with Mannitol busulfan. |
| Tacrolimus | The risk or severity of hyperkalemia can be increased when Tacrolimus is combined with Mannitol busulfan. |
| Alprenolol | The risk or severity of hyperkalemia can be increased when Alprenolol is combined with Mannitol busulfan. |
| Eprosartan | The risk or severity of hyperkalemia can be increased when Eprosartan is combined with Mannitol busulfan. |
| Quinapril | The risk or severity of hyperkalemia can be increased when Quinapril is combined with Mannitol busulfan. |
| Omapatrilat | The risk or severity of hyperkalemia can be increased when Omapatrilat is combined with Mannitol busulfan. |
| Zonisamide | The risk or severity of hyperkalemia can be increased when Zonisamide is combined with Mannitol busulfan. |
| Salicylic acid | The risk or severity of hyperkalemia can be increased when Salicylic acid is combined with Mannitol busulfan. |
| Meclofenamic acid | The risk or severity of hyperkalemia can be increased when Meclofenamic acid is combined with Mannitol busulfan. |
| Acetylsalicylic acid | The risk or severity of hyperkalemia can be increased when Acetylsalicylic acid is combined with Mannitol busulfan. |
| Pindolol | The risk or severity of hyperkalemia can be increased when Pindolol is combined with Mannitol busulfan. |
| Telmisartan | The risk or severity of hyperkalemia can be increased when Telmisartan is combined with Mannitol busulfan. |
| Oxaprozin | The risk or severity of hyperkalemia can be increased when Oxaprozin is combined with Mannitol busulfan. |
| Ketoprofen | The risk or severity of hyperkalemia can be increased when Ketoprofen is combined with Mannitol busulfan. |
| Balsalazide | The risk or severity of hyperkalemia can be increased when Balsalazide is combined with Mannitol busulfan. |
| Sulfamethoxazole | The risk or severity of hyperkalemia can be increased when Sulfamethoxazole is combined with Mannitol busulfan. |
| Felodipine | The risk or severity of hyperkalemia can be increased when Felodipine is combined with Mannitol busulfan. |
| Ketoconazole | The risk or severity of hyperkalemia can be increased when Ketoconazole is combined with Mannitol busulfan. |
| Irbesartan | The risk or severity of hyperkalemia can be increased when Irbesartan is combined with Mannitol busulfan. |
| Ibuprofen | The risk or severity of hyperkalemia can be increased when Ibuprofen is combined with Mannitol busulfan. |
| Nitrendipine | The risk or severity of hyperkalemia can be increased when Nitrendipine is combined with Mannitol busulfan. |
| Perhexiline | The risk or severity of hyperkalemia can be increased when Perhexiline is combined with Mannitol busulfan. |
| Heparin | The risk or severity of hyperkalemia can be increased when Heparin is combined with Mannitol busulfan. |
| Nifedipine | The risk or severity of hyperkalemia can be increased when Nifedipine is combined with Mannitol busulfan. |
| Amiodarone | The risk or severity of hyperkalemia can be increased when Amiodarone is combined with Mannitol busulfan. |
| Carvedilol | The risk or severity of hyperkalemia can be increased when Carvedilol is combined with Mannitol busulfan. |
| Itraconazole | The risk or severity of hyperkalemia can be increased when Itraconazole is combined with Mannitol busulfan. |
| Rescinnamine | The risk or severity of hyperkalemia can be increased when Rescinnamine is combined with Mannitol busulfan. |
| Propafenone | The risk or severity of hyperkalemia can be increased when Propafenone is combined with Mannitol busulfan. |
| Acebutolol | The risk or severity of hyperkalemia can be increased when Acebutolol is combined with Mannitol busulfan. |